Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.41 |
| ▸ | CA1 | P00915 | 10/20 | 0.41 |
| ▸ | MMP1 | P03956 | 9/20 | 0.41 |
| ▸ | MMP2 | P08253 | 9/20 | 0.41 |
| ▸ | MMP9 | P14780 | 9/20 | 0.41 |
| ▸ | MMP8 | P22894 | 9/20 | 0.41 |
| ▸ | MMP13 | P45452 | 9/20 | 0.41 |
| ▸ | F2 | P00734 | 4/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3756194 | 1.00 | CA2 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL575405 | 0.83 | CA2 (0.40) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL576166 | 0.81 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL979982 | 0.81 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL575657 | 0.81 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1768211 | 0.81 | CXCR2 (0.35) | — | |
| SCHEMBL1924669 | 0.81 | CXCR2 (0.35) | — | |
| SCHEMBL1768213 | 0.81 | CXCR2 (0.35) | — | |
| SCHEMBL3770785 | 0.80 | CA2 (0.38) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1923926 | 0.80 | CA2 (0.38) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8212065-B2 | Method for the production of optically active alpha alkyl carbonyl compounds | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2012-07-03 | — | — | US | disclosed |
| US-20100305352-A1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE ALPHA ALKYL CARBONYL COMPOUNDS | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305352-A1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE ALPHA ALKYL CARBONYL COMPOUNDS | ZNF787, ZKSCAN2, ERG28 | CA2 325/4885CA1 717/4885MMP1 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.